Close this search box.

We are creating some awesome events for you. Kindly bear with us.

HKBU and MedTech firm to partner on cell therapy research

mage Credits: HKBU, Press Release

The Department of Biology at Hong Kong Baptist University (HKBU) announced that it has signed a collaboration agreement with a Hong Kong-based investment holding company principally engaged in medical businesses.

Under the terms of the agreement, the two partners will jointly conduct in-depth research in the area of cell therapy and will focus in particular on the treatment of neurodegenerative diseases using stem cell harvest technology developed at HKBU.

As part of the collaboration, the MedTech firm will contribute a sum of HK$15 million to HKBU in support of a contract research related to cell culture technology and cell therapies that can potentially treat neurodegenerative and other incurable diseases.

This five-year in-depth research project will be conducted by a research team led by a professor from the Department of Biology at HKBU.

It is expected that the collaboration between HKBU and MedTech firm will develop a new therapeutic approach to the treatment of neurodegenerative diseases. The results are expected to benefit patients not only in the Greater China Region but also the world.

Neurodegenerative diseases are mainly caused by the death or degeneration of nerve cells in the brain. According to statistics published in 2015, over 100 million people worldwide suffer from neurodegenerative diseases. As populations around the world continue to age, it is predicted that more than 20% of the global population (around 2 billion people) will be aged 60 or above by 2050.

As a result, the number of patients suffering from neurodegenerative diseases will increase drastically and pose a threat to public health. At present, the drugs available to treat neurodegenerative diseases are not very effective and have many harmful side effects. Therefore, cell therapy is regarded as the most promising cure for such diseases.

The Department of Biology is committed to conducting cell therapy research for the treatment of neurodegenerative diseases. A series of the internationally influential research has been published and in some cases successfully commercialised.

The MedTech firm is an integrated healthcare enterprise in mainland China. It has established dominant positions in the medical devices and hospital market in the healthcare industry.

HKBU revolutionising MedTech

In the last 6 months alone HKBU has been paving the way in revolutionary biotechnology.

In December 2018, an HKBU student-developed software for severely disabled people. The student, in the Master of Science program in Advanced Information Systems, developed voice-control computer software for severely disabled people in spite of his own physical and speech disabilities, OpenGov Aisa reported.

The software, named “Cerebral Palsy to Joy (CP2Joy)”, is the first human-computer interface for severely disabled people in Hong Kong. It will enable those with severe disabilities to use the internet on their own, thereby reducing the digital divide.

Then in January 2019, OpenGov Asia reported that the University’s scholars had developed the first-ever system for rapid antibiotic resistance testing and analysis.

The new technology can provide information about drug-resistant pathogens present in patients, enabling doctors to accurately determine the effectiveness and appropriate dosage of antibiotics needed for effective treatment.

The new fully-automated system is 10-20 times faster, more accurate and can also be run at a much lower cost than the current AST methods which are only available in professional medical laboratories.

It is expected that the invention will aid diagnosis by providing doctors with a precise prescription which will significantly reduce the chance of antibiotic abuse or misuse. The team is planning to commercialise the system so that more people can benefit from the development.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


CTC Global Singapore, a premier end-to-end IT solutions provider, is a fully owned subsidiary of ITOCHU Techno-Solutions Corporation (CTC) and ITOCHU Corporation.

Since 1972, CTC has established itself as one of the country’s top IT solutions providers. With 50 years of experience, headed by an experienced management team and staffed by over 200 qualified IT professionals, we support organizations with integrated IT solutions expertise in Autonomous IT, Cyber Security, Digital Transformation, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Well-known for our strengths in system integration and consultation, CTC Global proves to be the preferred IT outsourcing destination for organizations all over Singapore today.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.